A plasma proteomic frailty signature for cardiovascular risk stratification: A multi-cohort study.
A protein signature in blood may help identify people at higher risk of heart failure before symptoms develop.
We examined frailty-CVD associations in the XiDu2017 cohort (n = 4323) and UK Biobank (UKB; n = 84,276) using logistic and Cox regression, respectively. PF showed incremental discrimination for selected outcomes, particularly heart failure.
What the study was
- Study design
- Validation study
- Population
- We examined frailty-CVD associations in the XiDu2017 cohort (n = 4323) and UK Biobank (UKB; n = 84,276) using logistic and Cox regression, respectively.
- Sample size
- 844
- Category
- Public Health
- Maturity
- Validated
- Journal
- International journal of cardiology. Heart & vasculature
Why it surfaced
Validation study assessed from PubMed metadata and abstract text; conservatively scored 8/10 under the v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.